Citation

BibTex format

@article{Plummer:2025:10.1016/j.xcrm.2025.102041,
author = {Plummer, R and Sodergren, MH and Hodgson, R and Ryan, BM and Raulf, N and Nicholls, JP and Reebye, V and Voutila, J and Sinigaglia, L and Meyer, T and Pinato, DJ and Sarker, D and Basu, B and Blagden, S and Cook, N and Evans, TRJ and Yachnin, J and Chee, CE and Li, D and El-Khoueiry, A and Diab, M and Huang, K-W and Pai, M and Spalding, D and Talbot, T and Noel, MS and Keenan, B and Mahalingam, D and Song, M-S and Grosso, M and Arnaud, D and Auguste, A and Zacharoulis, D and Storkholm, J and Mcneish, I and Habib, R and Rossi, JJ and Habib, NA},
doi = {10.1016/j.xcrm.2025.102041},
journal = {CELL REPORTS MEDICINE},
title = {TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors},
url = {http://dx.doi.org/10.1016/j.xcrm.2025.102041},
volume = {6},
year = {2025}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Plummer,R
AU  - Sodergren,MH
AU  - Hodgson,R
AU  - Ryan,BM
AU  - Raulf,N
AU  - Nicholls,JP
AU  - Reebye,V
AU  - Voutila,J
AU  - Sinigaglia,L
AU  - Meyer,T
AU  - Pinato,DJ
AU  - Sarker,D
AU  - Basu,B
AU  - Blagden,S
AU  - Cook,N
AU  - Evans,TRJ
AU  - Yachnin,J
AU  - Chee,CE
AU  - Li,D
AU  - El-Khoueiry,A
AU  - Diab,M
AU  - Huang,K-W
AU  - Pai,M
AU  - Spalding,D
AU  - Talbot,T
AU  - Noel,MS
AU  - Keenan,B
AU  - Mahalingam,D
AU  - Song,M-S
AU  - Grosso,M
AU  - Arnaud,D
AU  - Auguste,A
AU  - Zacharoulis,D
AU  - Storkholm,J
AU  - Mcneish,I
AU  - Habib,R
AU  - Rossi,JJ
AU  - Habib,NA
DO  - 10.1016/j.xcrm.2025.102041
PY  - 2025///
SN  - 2666-3791
TI  - TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors
T2  - CELL REPORTS MEDICINE
UR  - http://dx.doi.org/10.1016/j.xcrm.2025.102041
VL  - 6
ER  -
Download